There was no significant difference in the expression level of PDIA3 in the cancers with only normal tissue samples, including adrenocortical carcinoma (ACC), lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), acute myeloid leukemia (LAML), brain lower grade glioma (LGG), mesothelioma (MESO), ovarian serous cystadenocarcinoma (OV), testicular germ cell tumors (TGCT), uterine carcinosarcoma (UCS), and uveal melanoma (UVM). Here, PDIA3 is linked to diffuse large B-cell lymphoma.